ACRS - Aclaris Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ACRS is currently covered by 6 analysts with an average price target of $9.31. This is a potential upside of $7.4 (387.43%) from yesterday's end of day stock price of $1.91.

Aclaris Therapeutics's activity chart (see below) currently has 44 price targets and 56 ratings on display. The stock rating distribution of ACRS is 54.55% BUY and 45.45% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 28.79% with an average time for these price targets to be met of 160.45 days.

Highest price target for ACRS is $16, Lowest price target is $6, average price target is $7.83.

Most recent stock forecast was given by CHRISTOPHER RAYMOND from PIPER SANDLER on 10-Jul-2025. First documented stock forecast 02-Nov-2015.

Currently out of the existing stock ratings of ACRS, 12 are a BUY (54.55%), 10 are a HOLD (45.45%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$6

$4.05 (207.69%)

$13

2 months 9 days ago
(10-Jul-2025)

1/6 (16.67%)

$4.41 (277.36%)

354

Buy

$16

$14.05 (720.51%)

$16

2 months 25 days ago
(25-Jun-2025)

0/7 (0%)

$14.37 (881.60%)

Buy

$9

$7.05 (361.54%)

4 months 10 days ago
(09-May-2025)

0/8 (0%)

$7.74 (614.29%)

Buy

$8

$6.05 (310.26%)

10 months ago
(19-Nov-2024)

0/3 (0%)

$3.41 (74.29%)

Buy

$7

$5.05 (258.97%)

10 months ago
(19-Nov-2024)

1/4 (25%)

$2.41 (52.51%)

315

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ACRS (Aclaris Therapeutics) average time for price targets to be met?

On average it took 160.45 days on average for the stock forecasts to be realized with a an average price target met ratio 28.79

Which analyst has the current highest performing score on ACRS (Aclaris Therapeutics) with a proven track record?

DAVID STEINBERG

Which analyst has the most public recommendations on ACRS (Aclaris Therapeutics)?

David Steinberg has 9 price targets and 7 ratings on ACRS

Which analyst is the currently most bullish on ACRS (Aclaris Therapeutics)?

Pasha Sarraf with highest potential upside - $19.15

Which analyst is the currently most reserved on ACRS (Aclaris Therapeutics)?

Alex Thompson with lowest potential downside - -$0.95

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?